{
  "id": "Duval_CIBMTR_Score_for_Acute_Myelogenous_Leukemia_AML_Survival.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-07-07",
      "name": "Henrik Honkanen",
      "organisation": "Cambio CDS",
      "email": "henrik.honkanen@stud.ki.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict the overall survival in AML patients with relapsed/refractory disease undergoing myeloablative transplant.",
        "keywords": [
          "survival",
          "relapsed disease",
          "myeloablative transplant",
          "acute myeloid leukemia",
          "refractory disease",
          "hematopoietic stem cell transplant"
        ],
        "use": "Use in patients with relapsed or refractory active AML for whom hematopoietic stem cell transplant (HSCT) is being considered.\n\nScore interpretation:\n-Duval Score 0 - 3-year overall survival after transplantation 42%\n-Duval Score 1 - 3-year overall survival after transplantation 28%\n-Duval Score 2 - 3-year overall survival after transplantation15%\n-Duval Score â‰¥3 - 3-year overall survival after transplantation 6%",
        "misuse": "Do not use in patients with chronic myelogenous leukemia (CML) in blast crisis.",
        "copyright": "@Cambio CDS"
      }
    },
    "other_details": {
      "references": "1. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, De Lima M, Gupta V, Keating A. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. Journal of clinical oncology. 2010 Aug 10;28(23):3730."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-OBSERVATION.duval_cibmtr_score_for_acute_myelogenous_leukemia_aml_survival.v0",
        "template_id": "openEHR-EHR-OBSERVATION.duval_cibmtr_score_for_acute_myelogenous_leukemia_aml_survival.v0",
        "type": "INPUT",
        "elements": {
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0005]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0006]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          }
        }
      },
      "gt0009": {
        "id": "gt0009",
        "model_id": "openEHR-EHR-OBSERVATION.duval_cibmtr_score_for_acute_myelogenous_leukemia_aml_survival.v0",
        "template_id": "openEHR-EHR-OBSERVATION.duval_cibmtr_score_for_acute_myelogenous_leukemia_aml_survival.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0009]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          }
        }
      }
    },
    "rules": {
      "gt0002": {
        "id": "gt0002",
        "priority": 5,
        "when": [
          "$gt0004|Disease group|!=null",
          "$gt0005|Cytogenetics prior to HSCT|!=null",
          "$gt0006|HLA match group|!=null",
          "$gt0007|Circulating blasts|!=null",
          "$gt0008|Karnofsky or Lanksy scale|!=null"
        ],
        "then": [
          "$gt0010|Duval/CIBMTR total score|.magnitude=$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 4,
        "when": [
          "$gt0010|Duval/CIBMTR total score|.magnitude>=3"
        ],
        "then": [
          "$gt0011|Score interpretation|=local::at0014|3-year overall survival after transplantation is 6%|"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 3,
        "when": [
          "$gt0010|Duval/CIBMTR total score|.magnitude==2"
        ],
        "then": [
          "$gt0011|Score interpretation|=local::at0013|3-year overall survival after transplantation is 15%|"
        ]
      },
      "gt0013": {
        "id": "gt0013",
        "priority": 2,
        "when": [
          "$gt0010|Duval/CIBMTR total score|.magnitude==1"
        ],
        "then": [
          "$gt0011|Score interpretation|=local::at0012|3-year overall survival after transplantation is 28%|"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 1,
        "when": [
          "$gt0010|Duval/CIBMTR total score|.magnitude==0"
        ],
        "then": [
          "$gt0011|Score interpretation|=local::at0011|3-year overall survival after transplantation is 42%|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Duval/CIBMTR Score for Acute Myelogenous Leukemia (AML) Survival",
            "description": "Predicts overall survival in AML patients with relapsed/refractory disease undergoing myeloablative transplant."
          },
          "gt0002": {
            "id": "gt0002",
            "text": "Calculate Duval/CIBMTR score"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Disease group",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Cytogenetics prior to HSCT",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "HLA match group",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Circulating blasts",
            "description": "*At the time of transplant"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Karnofsky or Lanksy scale",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Duval/CIBMTR total score",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Score interpretation",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Score 0 interpretation"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Score 1 interpretation"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Score 2 interpretation"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Score 3 or more interpretation"
          }
        }
      }
    }
  }
}